Ribosome biogenesis protein BMS1 homolog (BMS1)

Ribosome biogenesis protein BMS1 homolog (BMS1) is an essential, evolutionarily conserved nucleolar GTPase involved in the processing of pre-ribosomal RNA at sites A0, A1, and A2, which are necessary steps for the synthesis and assembly of the 40S ribosomal subunit. Depletion or dysfunction of BMS1 impairs 35S pre-rRNA processing and ribosome assembly, thus impacting protein synthesis and cell viability[1][2][3][7]. In humans, BMS1 is encoded by the BMS1 gene located on chromosome 10[5]. - There is currently no evidence classifying BMS1 as a direct therapeutic target (such as a receptor, enzyme, transporter) for any approved or experimental drugs. - Its activity is essential for cellular protein translation but it is not known to be directly implicated as a target in cancer, inflammation, or other major disease mechanisms based on current genomic and protein databases[3][7]. - No approved drugs are known to specifically interact with BMS1, and it is not used as a biomarker or has recognized safety/toxicity concerns in the therapeutic setting. Summary: BMS1 is a critical ribosome biogenesis factor and GTPase required for early steps in 40S ribosome assembly and rRNA processing, functioning primarily in the nucleolus without direct clinical targeting or disease association as of the latest research[1][2][3][7].

Other names

BMS1BMS1LKIAA0187ribosome assembly protein BMS1 homologBMS1-likeACC